Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Porin Insertion in the Outer Mitochondrial Membrane01:12

Porin Insertion in the Outer Mitochondrial Membrane

4.9K
Porins are beta-barrel proteins translocated to the mitochondrial outer membrane through the TOM complex into the intermembrane space. Porin precursors bind TIM chaperones within the intermembrane space and are guided to the Sorting and Assembly Machinery complex or SAM complex on the outer mitochondrial membrane.
Three models describe the assembly of porins by the SAM complex and their insertion into the outer membrane. Model 1 suggests that porins are assembled outside the SAM channel as the...
4.9K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

13.5K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
13.5K
Protein Transport into the Inner Mitochondrial Membrane01:34

Protein Transport into the Inner Mitochondrial Membrane

5.0K
Nuclear encoded mitochondrial precursors are imported to the inner membrane in a multistep process involving two separate translocons, TIM22 and TIM23. TIM23 is a cation-selective pore that remains closed by the N terminal segment of the protein. Negative charges on the TIM23 act as a receptor for the incoming precursor, pulling the positively charged matrix-targeting sequence for peptide insertion and translocation.
Transport of mitochondrial precursors across the TIM23 channel is driven by...
5.0K
Mechanism of Filopodia Formation01:39

Mechanism of Filopodia Formation

3.3K
Filopodia are thin, actin-rich cellular protrusions that play an important role in many fundamental cellular functions. They vary in their occurrence, length, and positioning in different cell types, suggesting their diverse roles.
Their main function is to guide migrating cells during normal tissue morphogenesis or cancer metastasis by recognizing and making initial contacts with the extracellular matrix. However, they can also act as stationary cell anchors or help to establish communication...
3.3K
Structure of Porins01:21

Structure of Porins

4.0K
Mitochondria, chloroplasts, and gram-negative bacteria have transmembrane, beta-barrel proteins called porins to mediate the free diffusion of ions and metabolites across the membrane. Mitochondrial porin precursors contain conserved amino acid sequences called beta signals at their C-terminal. Beta signals have a  motif of PoXGXXHyXHy (Po-Polar, X-Any amino acid, G-Glycine, Hy-LargeHydrophobic), which are crucial for precursor recognition to initiate precursor assembly. Beta-barrel...
4.0K
Pinching-off of Coated Vesicles01:32

Pinching-off of Coated Vesicles

4.3K
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of β-Lapachone as a Potent USP22 Inhibitor That Suppresses Cancer Stemness and Enhances Chemosensitivity in Lung Adenocarcinoma.

International journal of molecular sciences·2026
Same author

Generation of mixed-valency, modular multispecific antibodies using disulfide-linked Fc-FcγR complexes.

Nature communications·2026
Same author

Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells.

bioRxiv : the preprint server for biology·2026
Same author

Colloidal Structure Engineering of Perovskite Precursor for Efficient Pure Blue LEDs with High Chlorine Content.

ACS applied materials & interfaces·2026
Same author

Association of pharmacokinetic biomarkers with early immune recovery following HLA-haploidentical hematopoietic cell transplantation.

Frontiers in immunology·2025
Same author

Single-residue engineering of lambda (λ) antibody light chains reduces conformational flexibility and enhances thermal stability.

Computational and structural biotechnology journal·2025

Related Experiment Video

Updated: Feb 17, 2026

A Paired Bead and Magnet Array for Molding Microwells with Variable Concave Geometries
11:42

A Paired Bead and Magnet Array for Molding Microwells with Variable Concave Geometries

Published on: January 28, 2018

9.2K

Meditope-Fab interaction: threading the hole.

Krzysztof P Bzymek1, Yuelong Ma1, Kendra N Avery1

  • 1Department of Molecular Medicine, Beckman Research Institute of City of Hope, 1710 Flower Street, Duarte, CA 91101, USA.

Acta Crystallographica. Section F, Structural Biology Communications
|December 5, 2017
PubMed
Summary
This summary is machine-generated.

Researchers modified a peptide called meditope to improve its binding to cetuximab Fab. A specific modification, carboxyethylarginine, significantly increased the interaction

Keywords:
X-ray crystallographymeditopemonoclonal antibodiessurface plasmon resonance

More Related Videos

Fabrication and Visualization of Capillary Bridges in Slit Pore Geometry
11:20

Fabrication and Visualization of Capillary Bridges in Slit Pore Geometry

Published on: January 9, 2014

9.3K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Related Experiment Videos

Last Updated: Feb 17, 2026

A Paired Bead and Magnet Array for Molding Microwells with Variable Concave Geometries
11:42

A Paired Bead and Magnet Array for Molding Microwells with Variable Concave Geometries

Published on: January 28, 2018

9.2K
Fabrication and Visualization of Capillary Bridges in Slit Pore Geometry
11:20

Fabrication and Visualization of Capillary Bridges in Slit Pore Geometry

Published on: January 9, 2014

9.3K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K

Area of Science:

  • Biochemistry
  • Structural Biology
  • Drug Discovery

Background:

  • Meditope is a cyclic peptide that binds to cetuximab Fab.
  • The binding site is located between the light and heavy chains of the antibody fragment.
  • Improving meditope-cetuximab Fab affinity is a therapeutic goal.

Purpose of the Study:

  • To enhance the binding affinity of meditope to cetuximab Fab.
  • To explore side chain modifications of Arg8 in meditope for increased interactions.
  • To investigate the structural and kinetic impact of these modifications.

Main Methods:

  • Chemical modification of meditope, including side chain extensions (n-butyl, n-octyl) and substitutions (hydroxyl, amine, carboxyl).
  • Determination of atomic structures of meditope-Fab complexes.
  • Measurement of binding kinetics and complex half-life.

Main Results:

  • Modified meditope extensions threaded through the cetuximab Fab binding site.
  • The carboxyethylarginine substitution demonstrated a favorable interaction with the Fab.
  • This modification increased the complex half-life threefold compared to unmodified meditope.

Conclusions:

  • Side chain modifications can enhance meditope-Fab interactions.
  • The carboxyethylarginine substitution offers a promising strategy for improving affinity.
  • These findings provide a foundation for designing future modifications to optimize binding affinity.